baber/WOPTO huggingface dataset:
Patent AP-1041-A (AP)
Title: Prevention of loss and restoration of bone mass by certain prostaglandin agonists.
Inventor: CAMERON KIMBERLY O
IPC: A61K31/47
Filed: 1997-12-18
Granted: 2002-02-01
Abstract: Prostaglandin agonists of formula (1), in which, for example, A is a sulphonyl or acyl group, B is N or CH, M contains a ring and K and Q are linking groups, methods of using such prostaglandin agonists, pharmaceutical compositions containing such prostaglandin _ . agonists and kits useful for the treatment of bone disorders including osteoporosis.
Patent AU-1077201-A (AU)
Title: Assigning agent-led chat sessions
Inventor: SHTIVELMAN YURI
IPC: G06F17/30
Filed: 2000-10-10
Abstract: In a communication center system wherein agents participate in and host communication sessions, a session management system has a data repository storing parameters regarding individual sessions in progress in the communication center system and agent parameters including one or both of minimum and maximum load capabilities for individual agents. A management software executes on a server associated with the communication center system, and calculates agent load level over chat sessions hosted by an individual agent, compares the calculated load level with one or both of minimum and maximum load for said agent, and adjusts agent assignment to sessions accordingly. In the case where agents are overloaded, additional agents are assigned to open sessions, and in the case where agents are underutilized, additional sessions may be assigned to the under-utilized agents. The sessions in a preferred embodiment are chat sessions. <IMAGE>
Patent AU-1188192-A (AU)
Title: Benzamides
Inventor: ASHTON MICHAEL JOHN
IPC: C07C255/57
Filed: 1992-01-28
Abstract: Benzamide derivatives of the formula (I): <CHEM> wherein R<1> represents alkyl, R<2> represents alkyl or mono-, bi- or tricycloalkyl, R<3> represents an optionally substituted phenyl, naphthyl or heterocyclyl group, and Z represents oxygen or sulphur, and when said heterocyclyl groups contain one or more nitrogen ring atoms, N-oxides thereof, and pharmaceutically acceptable salts thereof, possess useful pharmacological properties.
Patent AU-1252901-A (AU)
Title: Data compression through offset representation
Inventor: SMITH PETER D
IPC: G06T9/00
Filed: 2000-09-15
Abstract: A computing-device implemented method for compressing a data model, where such devices include a computer, personal digital assistant (PDA), home appliance, and the like. The data includes bandwidth intensive information such as that used in video conferencing, MPEG and equivalent types of digital video encoding, multi-media data transfers, and interactive gaming. In one implementation, a 3D model has objects defined therein. Each object is defined by plural data points that are transferred from a data provider to a recipient. Typically the provider and recipient are in communication over a network. For a first and a second data point defined in the model, first offsets are determined from the first data point for the second data point. The second data point can then be re-coded in terms of the determined first offsets. The first offsets are coded to require less data storage than required for the first data point, thus allowing them to be transferred more quickly. Second offsets can be cascaded off the first offsets for a third data point defined within the model.
Patent AU-1273800-A (AU)
Title: Method for controlling bearer properties
Inventor: SALONEN JANNE
IPC: H04L12/56
Filed: 1999-11-05
Abstract: The invention concerns the control of connections in cellular telecommunication systems. According to the invention, the available radio resources are controlled by allowing only certain conbinations of transport formats to be used by a single user. The inventive method restricts the combinations of bearer bit rates which can be used, without strictly limiting some bearers from using highest bit rates. This inventive approach allows flexible overall control of radio resources, while retaining the possibility of bearers to select between different bit rates.
Patent AU-1326000-A (AU)
Title: A method for preventing or retarding the formation of gas hydrates
Inventor: BAKEEV KIRILL N
IPC: C09K3/00
Filed: 1999-10-28
Abstract: A composition is provided herein for preventing or retarding the formation of gas hydrates or for reducing the tendency of gas hydrates to agglomerate, during the transport of a fluid comprising water and a hydrocarbon, through a conduit. The composition is a homopolymer of vinyl caprolactam having the low molecular weight in the range of 500 to 2500, or copolymers thereof, in a defined solvent. Such homopolymers and copolymers preferably are made and applied in the defined solvent, which, most preferably, is a glycol ether such as 2-butoxyethanol.
Patent AU-1358601-A (AU)
Title: Container for wet wipes
Inventor: BIANCHETTI GIULIA OTTAVIA
IPC: C11D17/04
Filed: 2000-11-02
Abstract: According to the present invention there is provided a sealable container. The container containing a substrate which incorporates a composition comprising an anionic surfactant, an nonionic surfactant and an amphoteric and/or zwitterionic surfactant.
Patent AU-1580392-A (AU)
Title: 6,9 bis(substituted-amino)benzo (g)isoquinoline-5,10-diones
IPC: A61K31/535
Filed: 1992-03-09
Abstract: A compound according to formula (I): <CHEM>  wherein R is  C1-C10 alkyl; phenyl or C7-C10 aralkyl; C2-C10 aklyl substituted with one or two substituents selected from the group consisting of OR1 and -NR2R3; C2-C10 alkyl interrupted by one or two oxygen atoms or by a member selected from the group consisting of -NR4-, cis -CH=CH, trans -CH=CH- and -C=C-, and optionally substituted with one or two hydroxy (OH) or -NR2R3 groups; and wherein R1 is selected from the group consisting of hydrogen, C1-C6 alkyl, phenyl, C7-C10 aralkyl, -CHO, -COR5-, -COOR5, -S(O2)R5 and C2-C6 alkyl optionally substituted with -NR2R3; R2 and R3 are the same or different and are selected from the group consisting of hydrogen, C1-C10 alkyl, C7-C10 aralkyl, phenyl, C2-C10 alkyl substituted with one or two hydroxy (OH) groups, -CHO, -COR5, -COOR5, and -S(O2)R5, R2 and R3 taken together with the nitrogen atom to which they are bound form an ethyleneimine ring or a 5- or 6-membered aromatic or non-aromatic heterocyclic ring optionally containing another heteroatom selected from the group consisting of sulfur, oxygen and nitrogen, R2 is H and R3 is -C(=NH)NH2 or R2 is -C(=NH)NH2 and R3 is H; R4 is selected from the group consisting of hydrogen, C1-C10 alkyl, C2-C10 hydroxyalkyl, C2-C10 alkyl substituted with -NR2R3, C7-C10 aralkyl, phenyl, -COR5, -COOR5 and -S(O2)R5; R5 is selected from the group consisting of C1-C10 alkyl, C7-C10 aralkyl,  alpha -,  beta -, or  gamma -naphthyl, phenyl, o-, m-, or p-tolyl as free bases and their salts with pharmaceutically acceptable acids, have been found to have cytostatic and anti-tumor activity.
Patent AU-1769097-A (AU)
Title: Method and apparatus for directional radio communication
Inventor: KATZ MARCOS
IPC: H01Q3/26
Filed: 1997-02-13
Abstract: A method of directional radio communication between a first station (BTS4) and a second station (MS) comprises the following steps. A plurality of consecutive signals are received at the first station (BTS4) from the second station (MS). The signals are each receivable from at least one of a plurality of different directions. For each of a plurality of sequential signals which are received by the first station (BTS4) from the second station (MS) the value of at least one parameter is determined. The value of at least one parameter is selected for a signal to be transmitted from the first station (BTS4) to the second station (MS), the value of the at least one parameter of the signal to be transmitted by the first station (BTS4) being selected in dependence on the determined values of the at least one parameter of the plurality of sequential signals.
Patent AU-1832700-A (AU)
Title: Embolization device
Inventor: MORAN CHRISTOPHER J M D
IPC: A61K35/38
Filed: 1999-11-24
Abstract: A medical device (40) including a collagenous biomaterial (10) for causing embolus and treating an aneurysm. The collagenous biomaterial (10) includes a small intestine submucosa (12) that is configured into various components (16) for causing a vascular occlusion or a packing aneurysm lumen.
Patent AU-1885692-A (AU)
Title: Extruded blends of thermoplastic and liquid crystalline polymers
IPC: B29C48/10
Filed: 1992-03-31
Abstract: The present invention relates to the extrusion of multiaxially oriented articles from blends containing thermoplastic flexible polymers and thermotropic liquid crystalline polymers. Articles having a controlled molecular orientation and a tailored coefficient of thermal expansion are also provided.
Patent AU-1897500-A (AU)
Title: Acidic superabsorbent polysaccharides
Inventor: THORNTON JEFFREY WILSON
IPC: A61L15/28
Filed: 1999-12-16
Abstract: A process is disclosed for producing an acidic superabsorbent polysaccharide derivative, comprising the steps of. (a) crosslinking at least one polysaceharide containing acidic groups, such as carboxymethyl cellulose and/or 6-carboxy stanch, with a crosslinking agent to produce a gel; (b) if necessary, adjusting the pH of the polysaccharide to a value between 3.5 and 5.5; (c) comminuting the acidified polysaccharide gel; and (d) drying the comminuted polysaccharide at elevated temperature. The superabsorbent polysaccharide obtainable by this process has a pH below 5 and provides odour control when contacted with malodorous fluids.
Patent AU-1961400-A (AU)
Title: Method for covering damaged protective layer areas, device for implementing saidmethod and transport system
Inventor: TAIANA PETER
IPC: B05C13/02
Filed: 2000-01-18
Abstract: The invention relates first of all to a method for covering areas of damaged protective coating on containers or the like, in which, according to the invention, protective coating material is stamped on to the zone in which the damaged areas occur. The invention also describes an apparatus for carrying out the method in which a carrier unit is provided for stamping protective coating material on to the damaged area. Apparatus is provided for positioning the carrier unit with respect to the container.
Patent AU-2189292-A (AU)
Title: Method and apparatus for controlling sleep disorder breathing
IPC: A61F5/56
Filed: 1992-06-12
Abstract: A method and device for controlling sleep disorder breathing utilizes variable pressure. The compressor supplies air at a relatively low pressure to the user's air passages while the user is asleep. A pressure transducer will monitor the pressure and convert the pressure into an electrical signal. The electrical signal is filtered and processed to compare it to the characteristics of waveforms that exists during snoring. If the envelope of the waveform exceeds an average threshold value in duration and in area, then the microprocessor will consider the envelope possibly associated with a snore. If a selected number of envelopes of this nature occur within a selected time period, then the microprocessor considers snoring to exist and increases the pressure of the compressor. If snoring is not detected within a certain time period, then the microprocessor lowers the level gradually.
Patent AU-2232395-A (AU)
Title: N-(pyrimidinyl)-aspartic acid analogs as interleukin-1beta converting enzyme inhibitors
Inventor: DOLLE ROLAND E
IPC: C07D239/47
Filed: 1995-03-29
Abstract: Disclosed are compounds, compositions and methods for inhibiting interleukin-1 beta  (1L- beta ) protease activity. The compounds, N-(pyrimidinyl)-aspartic acid  alpha -substituted methyl ketones and aspartic acid aldehydes, have the formula (I) set out herein. These compounds are inhibitors of 1 beta -converting enzyme and as such are useful whenever such inhibition is desired. For example, they may be used as research tools in pharmacological, diagnostic and related studies and in the treatment of diseases in mammals in which IL- beta  protease activity is implicated.
Patent AU-2277892-A (AU)
Title: Preparations comprising a fluorocarbon and a lipophilic/fluorophilic organic compound, and their uses
IPC: C09K23/00
Filed: 1992-07-15
Abstract: Fluorocarbon emulsions comprising a stabilizing, particle size controlling fluorophilic/hydrophilic compound which can have the formulaRF1-W-RH1(I)wherein RF1 is a linear, branched or cyclic C2-14 fluorocarbon group; RH1 is a linear, branched or cyclic C2-18 saturated or unsaturated hydrocarbon group; and W is absent or is a bivalent species chosen from the group consisting of -O-, -S-, or various fluorinated structures. Use of the fluorophilic/lipophilic compound in the dispersions of the invention provides stable particle size and efficient emulsification. The dispersions of the invention can comprise biologically useful additive and can be used for various purposes, as oxygen carriers, contrast agents, or diagnostic agents.
Patent AU-2280999-A (AU)
Title: Application of a layer of admixture in the web former unit of a board machine
Inventor: KINNUNEN JUHA S
IPC: D21H19/00
Filed: 1999-02-03
Abstract: The invention concerns a method for application of a layer of admixture in the web former unit of a board machine. The flow of fresh stock (11) is divided into at least two component stock flows (121 and 122), of which flows, to at least one component flow (121), which forms a face which will be placed against the face of the layer to be combined with it, at a point (141) before the pump (22), at a point (14a2), and/or at a point (143) after the machine screen, admixtures are added in order to increase the contents of fines in the layers and the bonding strength between the faces, and after this the component flows (121 and 122) are passed into the multi-layer headbox (44) and further into the gap former.
Patent AU-2457100-A (AU)
Title: Enhancement of bactericidal activity of neisseria antigens with oligonucleotidescontaining cg motifs
Inventor: GRANDI GUIDO
IPC: A61K39/39
Filed: 2000-02-09
Abstract: Immunogenic compositions (e.g. vaccines) comprising: (a) an immunostimulating amount of a Neisseria antigen (preferably N. meningitidis serogroup B); and (b) an immunostimulating amount of an adjuvant composition comprising an oligonucleotide comprising at least one CG motif. Component (b) may further comprise a second adjuvant. Component (a) may be selected from a variety of antigens. Adjuvant compositions comprising an oligonucleotide having at least one CG motif, and complete Freund's adjuvant (CFA) are also provided.
Patent AU-2806799-A (AU)
Title: Diagnosis of feline immunodeficiency virus infection using env/gag polypeptide markers
Inventor: GROAT RANDALL G
IPC: C07K7/08
Filed: 1999-05-11
Abstract: We disclose methods for determining whether a feline is infected with feline immunodeficiency virus ("FIV"). The methods involve the use of an antibody-binding composition that includes two enhanced polypeptides, one containing an immunogenic fragment of the FIV gag precursor p55 and the other containing an immunogenic fragment of the FIV env precursor gp130. Also disclosed are devices for practising these methods. <IMAGE>
Patent AU-2942095-A (AU)
Title: Hydrogenation of substrate and products manufactured according to the process
Inventor: HARROD MAGNUS
IPC: B01J23/72
Filed: 1995-07-03
Abstract: A typical traditional reactor for hydrogenation consists of a tank filled with a liquid and a gas and a small particle catalyst. The reaction is carried out at high pressures and high temperatures. Lack of gas on the catalyst surface limits the velocity of reaction. Much work has been done to increase the quantity of gas on the catalyst. It has not been possible to solve this problem effectively with the techniques of today. According to the invention an extra solvent is added to the reaction mixture. By bringing the whole mixture (solvent, substrate, hydrogen and reaction products) to super-critical or near-critical state, a substantially homogeneous mixture can be obtained. By this method it is possible to control the concentration of gas on the catalyst to the desired level. The velocity of reaction is thereby increased considerably. The hydrogenation reactions principally involved comprise hydrogenation of carbon-carbon double bonds (C=C) in lipids; hydrogenation of COOR to C-OH and HO-R to produce fatty alcohols; and direct hydrogenation of oxygen to hydrogen peroxide.
Patent AU-3118597-A (AU)
Title: Composite material for absorbing and dissipating body fluids and moisture
Inventor: HERMANN PAUL F
IPC: B32B5/32
Filed: 1997-05-07
Abstract: Layered composite materials adapted to be formed into predetermined shaped components disposed for contact with moisture and body fluids having a cover layer for contact with the moisture and body fluids and a foam layer including one or more sorbents in a hydrophilic polyurethane foam matrix, wherein the foam layer is bonded to the cover layer so that moisture and body fluids in contact with the cover layer are transferred through the cover layer to the foam layer. The foam layer is established by combining an aqueous mixture including the sorbent in a predetermined ratio with the hydrophilic polyurethane. The foam layer may include other active ingredients such as odor absorption and bactericidal components, thermal phase change components and finely ground rubber tire materials to vary the characteristics of the composite material. Additionally, citric acid and surfactant compounds may be used to increase the concentration of the sorbent in the aqueous mixture and maintain the pumping fluidity of the aqueous mixture. Methods for making the layered composite materials are also described.
Patent AU-3160884-A (AU)
Title: Formaldehyde-free aqueous polymer dispersion
Inventor: HARREUS ALBRECHT
IPC: C08J3/02
Filed: 1984-08-03
Abstract: 1. Claims for the Contracting states : BE, CH, DE, FR, GB, IT, LI, NL, SE Formaldehyde-free aqueous plastics dispersions based on a crosslinkable polymer of ethylenically unsaturated monomers containing N-methylolamide and/or N-methylol ether-amide groups, characterized in that the dispersions contain a compound of the formula I  see diagramm : EP0143175,P11,F1  in which n = 0 or 1, N = oxygen, -CH2 -, -CH(R)- or -N(R)-, R representing (C1 -C4 )-alkyl or (C1 -C4 )-alkylol, and R**1 and R**2 denote H or OH. 1. Claims for the Contracting state : AT Process for the preparation of formaldehyde-free aqueous plastics dispersions based on a crosslinkable polymer of ethylenically unsaturated monomers containing N-methylolamide and/or N-methylol ether-amide groups, characterized in that aqueous crosslinkable polymer dispersions containing N-methylolamide and/or N-methylol ether-amide groups, prepared in the usual manner, are mixed with a compound of the formula 1  see diagramm : EP0143175,P12,F1  in which n = 0 or 1, X = oxygen, -CH2 -, -CH(R)- or -N(R)- R representing (C1 -C4 )-alkyl or (C1 -C4 )-alkylol, and R**1 and R**2 denote H or OH.
Patent AU-3218293-A (AU)
Title: Surgical cassette
IPC: A61F9/007
Filed: 1993-02-02
Abstract: A cassette for use in combination with a surgical handpiece (10) and a control console (501) for controlling irrigation and/or aspiration fluid flows to the handpiece is disclosed, having a novel valve arrangement. The cassette comprises a housing (502) having an interface (504) adapted to be held in operative association with the control console (501). The cassette also comprises a means (516) for generating a partial vacuum through interaction with a motive force provided by the console. The valve means to control fluid flows through the cassette to the handpiece are operable by a valve actuator in the console and include a valve face (208,244) formed integrally in the interface (504) of the housing (502) and sealed by a resilient molding (262) defining a valve sealing face (235,259). <IMAGE>
Patent AU-3272695-A (AU)
Title: Immunoconjugates and humanized antibodies specific for b-cell lymphoma and leukemia cells
Inventor: LEUNG SHUI-ON
IPC: A61K47/48
Filed: 1995-08-11
Abstract: A chimeric LL2 monoclonal antibody is described in which the complementarity determining regions (CDRs) of the light and heavy chains of the murine LL2 anti-B-lymphoma, anti-leukemia cell monoclonal antibody has been recombinantly joined to the human kappa and IgG<SUB>1 </SUB>constant region domains, respectively, which retains the immunospecificity and B-cell lymphoma and leukemia cell internalization capacity of the parental murine LL2 monoclonal antibody, and which has the potential of exhibiting reduced human anti-mouse antibody production activity. A humanized LL2 monoclonal antibody is described in which the CDRs of the light and heavy chains have been recombinantly joined to a framework sequence of human light and heavy chains variable regions, respectively, and subsequently linked to human kappa and IgG<SUB>1 </SUB>constant region domains, respectively, which retains the immunospecificity and B-lymphoma and leukemia cell internalization capacities of the parental murine and chimeric LL2 monoclonal antibodies, and which has the potential for exhibiting reduced human anti-mouse antibody production activity. Vectors for producing recombinant chimeric and humanized chimeric monoclonal antibodies are provided. Isolated DNAs encoding the amino acid sequences of the LL2 variable light and heavy chain and CDR framework regions are described. Conjugates of chimeric and humanized chimeric LL2 antibodies with cytotoxic agents or labels find use in therapy and diagnosis of B-cell lymphomas and leukemias.
Patent AU-3286200-A (AU)
Title: Applicator brush for liquid or pasty means, especially for decorative cosmetics such as mascara and method for producing same
Inventor: WEIHRAUCH GEORG
IPC: A46B9/02
Filed: 2000-03-06
Abstract: An applicator brush for liquid or pasty media, especially for decorative cosmetics such as mascara. The brush comprises a rod-shaped support (11) which is provided with a plurality of injection-molded projections (12) on the outside thereof. The projections (12) are made of synthetic material, protrude radially in different directions and are arranged at a mutual distance from each other. The aim of the invention is to reliably obtain a good combing effect and equal appliance of the means to be applied. To this end, the projections (12) are provided with a cross-section which tapers towards the free end of the projections (12). The projections (12) and the support (11) are made from a flexible synthetic material, especially an elastomeric synthetic material.
Patent AU-3287993-A (AU)
Title: Fermoral cutting guide
Inventor: ASHBY ALAN M
IPC: A61F2/28
Filed: 1993-02-05
Abstract: An orthopaedic instrument for guiding means for preparing the distal end of a human femur to receive an endoprosthetic femoral component characterised by a base component (6,7,8) provided with guide means (8) for guiding cutting means for shaping all of the necessary surfaces (1,2,3,4,5) to receive the femoral component to be fitted once said base component (6,7,8) is fitted to the bone, means (31,27,40,60,80) for aligning said base component on the bone and means (9,27,28) for attaching said base component to the bone after alignment. <IMAGE>
Patent AU-3516989-A (AU)
Title: New medium and its application
IPC: G09F3/02
Filed: 1989-05-24
Abstract: The invention relates to a self-adhesive safety support (1) intended to be placed on a substrate. It consists of at least one printable planar structure, coated with a layer of adhesive, the planar structure and the adhesive being such that the layer of adhesive is partially absorbed into the thickness of the planar structure. The planar structure is preferably a sheet of natural and/or synthetic fibres whose degree of print writing adhesive bonding is 5. Application especially as means preventing the falsification of passports. <IMAGE>